Zenas BioPharma, Inc. (ZBIO) EBIT Margin (2023 - 2026)
Zenas BioPharma's EBIT Margin was -10765.90% in Q2 2026.
Powered by 
Analysis
Zenas BioPharma, Inc. (ZBIO) EBIT Margin (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zenas BioPharma's EBIT Margin was -47557.30% through Jun 30, 2026, down 46296.63 percentage points year-over-year; for FY2025, it came in at -3830.57%, down 552.81 percentage points from FY2024.
- In earlier years, EBIT Margin was -3277.76% in FY2024 (-3203.47 pp) and -74.29% in FY2023.
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q1 2025.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,765.90% |
| Mar 31, 2025 | -373.30% |
| Dec 31, 2024 | -1,112.46% |
| Sep 30, 2023 | 71.25% |
API Access
Zenas BioPharma, Inc. EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();